NCT06932926

Brief Summary

The goal of this clinical trial is to to assess the remineralization potential of Egg shell hydrogel versus fluoride varnish in early carious white spot lesions in anterior primary teeth. The main question it aims to answer is:What is the remineralization potential of egg shell hydrogel on early carious white spot lesions compared to fluoride varnish in anterior primary teeth? Researcher will compare egg shell hydrogel with fluoride varnish to see if it is able to promote lesion remineralization. interventions that will be given to participasnts: egg shell hydrogel \& five percent sodium fluoride varnish

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Sep 2025

Shorter than P25 for phase_2

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

April 10, 2025

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Remineralization potential.

    change in minerals content of the lesion , will be assessed using diagnodent scores ( minimum value is 0 and maximum value is 99 ) higher scores means worse outcome .

    at 6th , 18 and 30th week

Secondary Outcomes (2)

  • Activity of the lesion

    will be assessed using Nyvad's criteria at 6th , 18 and 30th week

  • Oral hygiene

    at 6th , 18 and 30th week

Study Arms (2)

Egg shell hydrogel.

EXPERIMENTAL
Drug: Egg shell hydrogel

Fluoride varnish.

ACTIVE COMPARATOR

five percent sodium fluoride varnish (Charm varnish -Dentkist- Korea).

Drug: Fluoride varnish

Interventions

I. Nano-eggshell powder preparation: After cleaning, A small crack will be made in each eggshell to split it into two halves to evacuate the content. The eggshells will be disinfected in a hot water at 100°C for 10 minutes to facilitate the detachment of the inner membrane. They will be exposed to steam sterilization. Then they will be crushed using a sterile mortar and pestle. The crushed particles will be milled using a zirconia ball-milling machine at 200 rpm . This will result in a nano-sized eggshell powder to incorporate them into a gel form. II. Preparation of eggshell hydrogel formulations: through dispersing a suitable concentration of egg shell powder in distilled water, followed by dissolving the gelling agent; sodium carboxymethyl cellulose at a concentration of 5-10% under continuous stirring. The formed hydrogel will be kept at 8°C for a period of 24 hours before further use. This will produce a paste of consistency that is appropriate for handling and application.

Egg shell hydrogel.

five percent sodium fluoride varnish (Charm varnish -Dentkist- Korea).

Fluoride varnish.

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 3 to 5 years, in good general health, and medically free.
  • Prescence of at least one WSL on anterior primary teeth with an ICDAS II score of one or two.
  • Cooperative patients who will comply with follow-ups.
  • Parents who accept to sign informed consent.

You may not qualify if:

  • Uncooperative children.
  • Children with a physical disability or medical disability.
  • Children with teeth that shows enamel hypoplasia.
  • Children that have received a fluoride supplement or professional topical fluoride application at least 3 months before the study.
  • Parents refuse to give written formed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

sara B youssef, bachelor degree of dentistry

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 10, 2025

First Posted

April 17, 2025

Study Start

September 1, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

May 15, 2025

Record last verified: 2025-05